US Stock MarketDetailed Quotes

ACIU AC Immune

Watchlist
  • 3.580
  • +0.280+8.48%
Close May 14 16:00 ET
  • 3.500
  • -0.080-2.23%
Post 19:56 ET
354.06MMarket Cap-5070P/E (TTM)

AC Immune Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AC Immune Earnings Date

Currency: CHF

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.18

+14.29%
Analyst Rating

Buy

Apr 30, 2024

AC Immune Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CHF

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 500.000K--
--2024/Q2-- / 500.000K--
--2024/Q10.000 / 5.325M--
--2023/Q414.801M / 10.033M--
--2023/Q30.000 / 21.200M--
--2023/Q20.000 / 1.667M--
--2023/Q10.000 / 0.000--
Mar 16, 20232022/Q41.000K / 1.600M--
--2022/Q33.934M / 350.000K--
--2022/Q20.000 / 350.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 500.000K--
--2024/Q2-- / 500.000K--
--2024/Q10.000 / 5.325M--
--2023/Q414.801M / 10.033M--
--2023/Q30.000 / 21.200M--
--2023/Q20.000 / 1.667M--
--2023/Q10.000 / 0.000--
Mar 16, 20232022/Q41.000K / 1.600M--
--2022/Q33.934M / 350.000K--
--2022/Q20.000 / 350.000K--

Unlock Free Earnings Estimates

AC Immune Earnings Reports

  • AC Immune | 6-K: Report of foreign private issuer (related to financial reporting)

    May 13 18:18

  • AC Immune | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 14 19:48

  • AC Immune | 20-F: Registration statement / Annual report / Transition report

    Mar 14 19:34

  • AC Immune | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 19, 2023 21:53

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+1.02%